Cite
Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.
MLA
Sher, David J., et al. “Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 105, no. 1, Sept. 2019, pp. 110–18. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2019.03.010.
APA
Sher, D. J., Timmerman, R. D., Nedzi, L., Ding, C., Pham, N.-L., Zhao, B., & Sumer, B. D. (2019). Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer. International Journal of Radiation Oncology, Biology, Physics, 105(1), 110–118. https://doi.org/10.1016/j.ijrobp.2019.03.010
Chicago
Sher, David J., Robert D. Timmerman, Lucien Nedzi, Chuxiong Ding, Nhat-Long Pham, Bo Zhao, and Baran D. Sumer. 2019. “Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.” International Journal of Radiation Oncology, Biology, Physics 105 (1): 110–18. doi:10.1016/j.ijrobp.2019.03.010.